1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Sirtex Medical Acquires BlackSwan Vascular

M&A Deal Summary

Sirtex Medical Acquires BlackSwan Vascular

On December 9, 2020, Sirtex Medical acquired medical products company BlackSwan Vascular

Acquisition Highlights
  • This is Sirtex Medical’s 1st transaction in the Medical Products sector.
  • This is Sirtex Medical’s 1st transaction in the United States.
  • This is Sirtex Medical’s 1st transaction in California.

M&A Deal Summary
Date 2020-12-09
Target BlackSwan Vascular
Sector Medical Products
Buyer(s) Sirtex Medical
Deal Type Add-on Acquisition

Target

BlackSwan Vascular

Hayward, California, United States
BlackSwan Vascular, Inc. is focused on the development of liquid embolic products tailored for use in peripheral vascular applications. BlackSwan Vascular is based in Hayward, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sirtex Medical

Sydney, Australia
Category Company
Sector Life Science
Employees226
Revenue 129M AUD (2014)
DESCRIPTION

Sirtex Medical Ltd. is a global life-sciences company that develops and delivers effective oncology treatments using novel small particle technology. Sirtex Medical Limited is an Australian company with an approved cancer treatment supplied globally. Sirtex's main commercialised product is a targeted radioactive treatment for liver cancer called SIR-Spheres microspheres. Sirtex Medical is based in Sydney, Australia.

DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal